ProfileGDS4718 / 218159_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 87% 87% 83% 89% 86% 91% 86% 87% 87% 87% 89% 86% 88% 97% 89% 90% 89% 87% 91% 79% 88% 87% 89% 89% 86% 95% 87% 93% 86% 90% 86% 92% 84% 88% 90% 87% 85% 86% 87% 83% 88% 82% 92% 85% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.7779287
GSM549102patient 115, normal, homogenized [OPG study]8.6546987
GSM549104patient 119, normal, homogenized [OPG study]8.2403183
GSM549108patient 138, normal, homogenized [OPG study]8.8784289
GSM549119patient 077, normal, homogenized [OPG study]8.5743186
GSM549133patient 032, cancer, homogenized [OPG study]9.4105991
GSM549139patient 042, cancer, homogenized [OPG study]8.5613286
GSM549099patient 107, normal, homogenized [OPG study]8.6760287
GSM549109patient 139, normal, homogenized [OPG study]8.7310987
GSM549110patient 046, normal, homogenized [OPG study]8.6792587
GSM549114patient 063, normal, homogenized [OPG study]9.2394589
GSM549122patient 082, normal, homogenized [OPG study]8.5583186
GSM549134patient 033, cancer, homogenized [OPG study]8.9695688
GSM549136patient 036, cancer, homogenized [OPG study]10.782397
GSM549140patient 044, cancer, homogenized [OPG study]9.1529289
GSM549111patient 047, normal, homogenized [OPG study]9.2980790
GSM549113patient 057, normal, homogenized [OPG study]9.2599589
GSM549132patient 031, cancer, homogenized [OPG study]8.6776887
GSM549137patient 038, cancer, homogenized [OPG study]9.2590591
GSM549142patient 047, cancer, homogenized [OPG study]7.5178579
GSM549100patient 110, normal, homogenized [OPG study]8.8654388
GSM549107patient 135, normal, homogenized [OPG study]8.8200787
GSM549115patient 068, normal, homogenized [OPG study]9.2660589
GSM549116patient 072, normal, homogenized [OPG study]9.1648689
GSM549120patient 078, normal, homogenized [OPG study]8.597686
GSM549131patient 030, cancer, homogenized [OPG study]10.162295
GSM549118patient 074, normal, homogenized [OPG study]8.796287
GSM549129patient 027, cancer, homogenized [OPG study]9.5661493
GSM549123patient 088, normal, homogenized [OPG study]8.6847886
GSM549124patient 006, cancer, homogenized [OPG study]9.0506190
GSM549126patient 015, cancer, homogenized [OPG study]8.6004586
GSM549128patient 025, cancer, homogenized [OPG study]9.5583592
GSM549103patient 117, normal, homogenized [OPG study]8.156384
GSM549117patient 073, normal, homogenized [OPG study]9.0244788
GSM549138patient 041, cancer, homogenized [OPG study]9.1557490
GSM549141patient 045, cancer, homogenized [OPG study]8.8415987
GSM549130patient 028, cancer, homogenized [OPG study]8.391685
GSM549101patient 111, normal, homogenized [OPG study]8.5280786
GSM549105patient 128, normal, homogenized [OPG study]8.6784587
GSM549106patient 134, normal, homogenized [OPG study]8.3455783
GSM549112patient 048, normal, homogenized [OPG study]8.8839788
GSM549125patient 011, cancer, homogenized [OPG study]8.0015482
GSM549127patient 024, cancer, homogenized [OPG study]9.4059892
GSM549135patient 035, cancer, homogenized [OPG study]8.5913285